Page last updated: 2024-09-04

rhodioloside and Ovarian Neoplasms

rhodioloside has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cholujova, D; Duraj, J; Galova, E; Horvathova, E; Karnisova Potocka, E; Klapakova, M; Mastihuba, V; Mastihubova, M; Sevcovicova, A; Zduriencikova, M	1

Other Studies

1 other study(ies) available for rhodioloside and Ovarian Neoplasms

Article	Year
Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro. Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:3 Topics: Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Comet Assay; DNA Damage; Drug Antagonism; Drug Synergism; Female; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Ovarian Neoplasms; Phenols; Protective Agents; Reproducibility of Results; Signal Transduction	2018

Article

Year

Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro.

Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:3

Topics: Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Comet Assay; DNA Damage; Drug Antagonism; Drug Synergism; Female; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Ovarian Neoplasms; Phenols; Protective Agents; Reproducibility of Results; Signal Transduction

2018